A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area.
about
A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A phase I, open-label trial on ...... e living in a TB-endemic area.
@en
A phase I, open-label trial on ...... e living in a TB-endemic area.
@nl
type
label
A phase I, open-label trial on ...... e living in a TB-endemic area.
@en
A phase I, open-label trial on ...... e living in a TB-endemic area.
@nl
prefLabel
A phase I, open-label trial on ...... e living in a TB-endemic area.
@en
A phase I, open-label trial on ...... e living in a TB-endemic area.
@nl
P2093
P2860
P50
P1433
P1476
A phase I, open-label trial on ...... le living in a TB-endemic area
@en
P2093
Ahmed Bedru
Asfawesen G Yohannes
Howard Engers
Ingrid Kromann
Jemal Ahmed
Jemal Hussein
Lawrence Yamuah
Markos Abebe
Menberework Chanyalew
Peter Bang
P2860
P2888
P356
10.1186/S13063-017-2354-0
P577
2018-01-10T00:00:00Z
P6179
1100302304